Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kristy Kemmerer"'
Autor:
Xin Miao, Liviawati S. Wu, Shun Xin Wang Lin, Yan Xu, Yang Chen, Yuki Iwaki, Rachel Kobos, Tara Stephenson, Kristy Kemmerer, Clarissa M. Uhlar, Arnob Banerjee, Jenna D. Goldberg, Danielle Trancucci, Raluca Verona, Lixia Pei, Yaming Su, Daniele Ouellet, Alfred L. Garfall, Amrita Y. Krishnan, Saad Usmani, Suzette Girgis, Honghui Zhou
Publikováno v:
Blood. 140:4382-4383
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e83f00b628552ec8dfd3e2da26c04c4a
https://doi.org/10.1182/blood-2022-162859
https://doi.org/10.1182/blood-2022-162859
Autor:
Maria-Victoria Mateos, Saad Z. Usmani, Arnob Banerjee, Jenna D. Goldberg, Jesús F. San Miguel, Laura Rosiñol, Tara Stephenson, Shun Xin Wang Lin, Albert Oriol, Alfred L. Garfall, Ajai Chari, Suzette Girgis, Kristy Kemmerer, Jennifer Smit, Niels W.C.J. van de Donk, Jeffrey R. Infante, Yusri Elsayed, Hareth Nahi, Amrita Krishnan, Homer Adams
Publikováno v:
Journal of Clinical Oncology. 38:100-100
100 Background: Teclistamab (JNJ-64007957) is a bispecific BCMA x CD3 antibody that induces T cell-mediated cytotoxicity against BCMA-expressing myeloma cells. Initial results from an ongoing study of teclistamab in RRMM (NCT03145181) are presented.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e4a8a61bdec8304330d9cdbe74e2c6
https://doi.org/10.1200/jco.2020.38.15_suppl.100
https://doi.org/10.1200/jco.2020.38.15_suppl.100